BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient ...(ip product TrialCENTRALNet(SM) which als...),Health

Date:6/25/2008

ip product, TrialCENTRALNet(SM), which also serves as the technology backbone. TrialCENTRALNet provides an online infrastructure for planning, conducting and managing patient recruitment, instantly centralizing all related communications, data, reporting, and information for a single clinical study, or a suite of studies.

"Through our hands-on experience with hundreds of clinical trials, we've learned that it's not a matter of spending more time on recruitment; it's about recognizing patient recruitment as a distinct discipline and giving all study community members access to its principles," says Bachenheimer. "BBK's current initiatives are designed to do just that."

BBK and TCN e-Systems will showcase "Center of Excellence" and QuickTrainer at the 44th Annual Meeting of the Drug Information Association in Boston from June 22 - 26, 2008 at booth #711.

About BBK Worldwide

Founded in 1983 by Joan F. Bachenheimer and Bonnie A. Brescia, BBK Worldwide is a patient recruitment and e-business solution company for the clinical R&D and product marketing segments of the pharmaceutical, biotechnology, and medical device industries. BBK has helped to accelerate time to market for new medicines and treatments by successfully supporting hundreds of clinical studies in more than 60 countries, and in all major therapeutic areas. Staffed by some of the industry's principal thought leaders, BBK continually contributes ideas that advance the clinical development cycle. (http://www.bbkworldwide.com)

About TCN e-Systems, LLC

TCN e-Systems, located in Newton, Mass., is an e-recruitment company focused on streamlining patient enrollment for life-sciences companies through Web-based product suites that are designed to respond to the six enrollment risk areas. Founded in October 2006 by Joan F. Bachenheimer and Bonnie A. Brescia, also founding principals of industry-leading patient recruitment
'/>"/>

SOURCE BBK Worldwide Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
2. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
7. Getty Images Celebrates Conclusion of Change Me Imagery Forum
8. Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
9. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
10. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
11. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization